JP Patent

JP7749608B2 — 血液悪性腫瘍およびユーイング肉腫を処置するための方法

Assigned to Kura Oncology Inc · Expires 2025-10-06 · 1y expired

What this patent protects

Patent listed against Komzifti.

Drugs covered by this patent

Komzifti (ZIFTOMENIB) · Kura

Patent Metadata

Patent number: JP7749608B2
Jurisdiction: JP
Classification: —
Expires: 2025-10-06
Drug substance claim: No
Drug product claim: No
Assignee: Kura Oncology Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.